ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
InflaRx snags $55M for inflammatory, autoimmune trials
fiercebiotech
October 16, 2017InflaRx has raised $55 million (€47 million) in a new funding round. The series D follows fast after InflaRx established the potential of its anti-human complement factor C5a monoclonal antibody IFX-1 with phase 2a data.
Pharma Sources Insight January 2025
